'Stuffed': users of supplementary patented components in drug combos can be sued - European court
This article was originally published in Scrip
Executive Summary
A recent decision from the Court of Justice of the European Union has shed more light on the messy regulations governing supplementary protection certificates (which give five years extra IP protection) and the use of certificated-protected components in combination products.